| Literature DB >> 34858506 |
Emanuela Serritella1, Gabriella Galluccio1, Alessandra Impellizzeri1, Paola Di Giacomo1, Carlo Di Paolo1.
Abstract
PURPOSE: This study aimed to compare the effectiveness of three acupuncture methods for temporomandibular disorders- (TMDs-) related pain.Entities:
Year: 2021 PMID: 34858506 PMCID: PMC8632462 DOI: 10.1155/2021/1286570
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram of patient enrollment and interventions.
Baseline characteristics of the participants.
| Characteristics | Groups |
| |||
|---|---|---|---|---|---|
| BA group ( | EA group ( | CA group ( | |||
| Age, years, mean (SD) | 48.25 (15.7) | 38.50 (13.67) | 48.05 (14.06) | 0.0609 | |
|
| |||||
| Initial pain (VNS), mean (SD) | TMJ | 38.75 (38.45) | 31.00 (42.66) | 24.5 (33.95) | 0.5076 |
| Masticatory muscle | 34.00 (37.79) | 33.50 (38.45) | 39.5 (38.72) | 0.8960 | |
| Head | 63.25 (31.13) | 69.00 (25.73) | 56.00 (32.83) | 0.3966 | |
| Neck | 64.75 (33.54) | 64.5 (36.77) | 59.25 (33.65) | 0.8522 | |
|
| |||||
| Gender, number (%) | Female | 17 (85) | 16 (80) | 17 (85) | 0.8869 |
| Male | 3 (15) | 4 (20) | 3 (15) | ||
|
| |||||
| TMD diagnosis, number (%) | Arthralgia | 6 (30) | 3 (15) | 7 (35) | 0.4181 |
| Myalgia | 13 (65) | 13 (65) | 8 (40) | ||
| DDWRa | 3 (15) | 6 (30) | 5 (25) | ||
|
| |||||
| Side, number (%) | Right | 3 (15) | 2 (10) | 1 (5) | 0.5362 |
| Left | 3 (15) | 1 (5) | 1(5) | ||
| Both | 14 (70) | 17 (85) | 18 (90) | ||
BA group, body acupuncture treatment; EA group, electroacupuncture treatment; CA group, acupuncture + cupping treatment. aDisc Displacement with Reduction. p value for the comparison of the age and pain distributions among groups (one-way ANOVA). p value for the comparison of the gender, diagnosis, and side distributions among groups (Chi-square test).
Figure 2Pain distribution between BA, EA, and CA at T0, T1, AND T2: (a) TMJ pain; (b) muscle pain; (c) headache; (d) neck pain.
Comparisons of pain scores (VNS) within groups after acupuncture treatments (T1) and follow-up visit (T2) (n = 20 in each group); mean ± SD values.
| Group | T0 | T1 | T2 |
| P0-1 | P0-2 |
|---|---|---|---|---|---|---|
|
| ||||||
| BA group | 38.75 ± 38.45 | 18.00 ± 24.46 | 16.00 ± 22.57 |
|
|
|
| EA group | 31.00 ± 42.66 | 13.00 ± 26.77 | 11.00 ± 24.47 | 0.247 |
|
|
| CA group | 24.50 ± 33.96 | 8.00 ± 17.04 | 6.50 ± 14.24 |
|
|
|
|
| ||||||
| BA group | 34.00 ± 37.79 | 22.50 ± 28.40 | 21.00 ± 27.51 | 0.118 |
|
|
| EA group | 35.50 ± 38.45 | 9.00 ± 16.83 | 8.00 ± 14.72 |
|
|
|
| CA group | 39.50 ± 38.73 | 16.50 ± 25.19 | 16.00 ± 24.58 |
|
|
|
|
| ||||||
| BA group | 63.25 ± 31.13 | 30.50 ± 32.84 | 28.50 ± 31.00 |
|
|
|
| EA group | 69.00 ± 25.73 | 22.50 ± 28.45 | 17.50 ± 26.73 |
|
|
|
| CA group | 56.00 ± 32.83 | 22.50 ± 25.31 | 19.00 ± 22.92 |
|
|
|
|
| ||||||
| BA group | 64.75 ± 33.54 | 37.50 ± 31.44 | 38.50 ± 32.00 |
|
|
|
| EA group | 64.50 ± 36.77 | 24.00 ± 25.42 | 23.50 ± 25.19 |
|
|
|
| CA group | 59.25 ± 33.65 | 24.50 ± 25.02 | 25.00 ± 24.39 |
|
|
|
VNS, verbal numeric scale; SD, standard deviation. BA group, body acupuncture; EA group, electroacupuncture; CA group, acupuncture + cupping. PT, p value for the within-group comparison (Friedman test); P0-1, p value for the comparison of baseline (T0) and after 4 weeks (T1) scores (Wilcoxon signed-rank test); P0-2, p value for the comparison of baseline (T0) and after 8 weeks (T2) scores (Wilcoxon signed-rank test).
Comparisons of the results of the BPI questionnaire between and within groups after acupuncture treatments (T1) and at follow-up visit (T2) (n = 20 in each group); mean ± SD values.
| Group | T0 | T1 | T2 |
| P0-1 | P0-2 |
|---|---|---|---|---|---|---|
|
| ||||||
| BA group | 4.45 ± 3.53 | 2.30 ± 2.66 | 2.40 ± 2.72 |
|
|
|
| EA group | 4.25 ± 2.99 | 2.00 ± 2.69 | 1.75 ± 2.40 |
|
|
|
| CA group | 4.45 ± 2.11 | 2.35 ± 2.18 | 2.45 ± 2.37 |
|
|
|
|
| 0.954 | 0.678 | 0.529 | |||
| P1-2 | 0.785 | 0.587 | 0.469 | |||
| P1-3 | 0.870 | 0.782 | 0.803 | |||
| P2-3 | 0.838 | 0.374 | 0.249 | |||
|
| ||||||
| BA group | 6.25 ± 3.07 | 3.40 ± 2.94 | 3.25 ± 2.65 |
|
|
|
| EA group | 5.30 ± 2.96 | 2.05 ± 2.33 | 1.75 ± 1.94 |
|
|
|
| CA group | 6.25 ± 2.29 | 3.30 ± 2.25 | 3.35 ± 2.32 |
|
|
|
|
| 0.561 |
| 0.059 | |||
| P1-2 | 0.279 |
| 0.074 | |||
| P1-3 | 0.623 | 0.830 | 0.816 | |||
| P2-3 | 0.576 |
|
| |||
|
| ||||||
| BA group | 3.05 ± 3.68 | 1.40 ± 2.66 | 1.45 ± 2.78 | 0.089 | 0.175 | 0.196 |
| EA group | 1.45 ± 2.50 | 0.60 ± 1.14 | 0.60 ± 1.14 | 0.549 | 0.491 | 0.491 |
| CA group | 2.30 ± 2.87 | 1.20 ± 1.85 | 1.20 ± 1.85 | 0.091 | 0.252 | 0.252 |
|
| 0.337 | 0.675 | 0.675 | |||
| P1-2 | 0.156 | 0.582 | 0.582 | |||
| P1-3 | 0.671 | 0.922 | 0.922 | |||
| P2-3 | 0.276 | 0.340 | 0.340 | |||
|
| ||||||
| BA group | 4.10 ± 3.51 | 2.30 ± 3.06 | 2.35 ± 3.12 |
|
|
|
| EA group | 3.60 ± 3.22 | 1.75 ± 2.47 | 1.65 ± 2.28 |
|
|
|
| CA group | 4.00 ± 2.83 | 2.00 ± 2.27 | 2.30 ± 2.41 |
|
|
|
|
| 0.154 | 0.875 | 0.582 | |||
| P1-2 | 0.097 | 0.677 | 0.589 | |||
| P1-3 | 0.097 | 0.988 | 0.673 | |||
| P2-3 | 1 | 0.641 | 0.284 | |||
|
| ||||||
| BA group | 3.95 ± 3.17 | 2.15 ± 2.60 | 2.30 ± 2.77 |
|
|
|
| EA group | 2.60 ± 2.76 | 1.05 ± 1.67 | 1.10 ± 1.55 |
|
|
|
| CA group | 3.70 ± 2.30 | 2.60 ± 2.54 | 2.70 ± 2.72 |
|
|
|
|
| 0.266 | 0.092 | 0.186 | |||
| P1-2 | 0.193 | 0.239 | 0.390 | |||
| P1-3 | 0.753 | 0.364 | 0.443 | |||
| P2-3 | 0.132 |
| 0.053 | |||
|
| ||||||
| BA group | 4.80 ± 3.30 | 2.95 ± 2.84 | 3.10 ± 2.83 |
|
|
|
| EA group | 4.50 ± 3.47 | 0.95 ± 1.05 | 1.75 ± 1.77 |
|
|
|
| CA group | 5.05 ± 3.14 | 3.65 ± 3.12 | 3.95 ± 3.05 |
|
|
|
|
| 0.874 |
| 0.062 | |||
| P1-2 | 0.775 |
| 0.155 | |||
| P1-3 | 0.796 | 0.484 | 0.317 | |||
| P2-3 | 0.614 |
|
| |||
|
| ||||||
| BA group | 5.05 ± 3.89 | 3.35 ± 3.98 | 3.35 ± 3.98 |
|
|
|
| EA group | 3.05 ± 3.27 | 1.35 ± 2.50 | 1.40 ± 2.54 |
|
|
|
| CA group | 3.65 ± 3.12 | 2.30 ± 2.49 | 2.40 ± 2.68 |
|
|
|
|
| 0.222 | 0.210 | 0.224 | |||
| P1-2 | 0.101 | 0.142 | 0.147 | |||
| P1-3 | 0.281 | 0.757 | 0.790 | |||
| P2-3 | 0.419 | 0.107 | 0.118 | |||
VNS, verbal numeric scale; SD, standard deviation. BA group, body acupuncture; EA group, electroacupuncture; CA group, acupuncture + cupping. p, p value for the comparison among groups (one-way ANOVA on ranks); P1–2, p value for multiple comparisons of BA group and EA group (Bonferroni-corrected post hoc test); P1-3, p value for multiple comparisons of BA group and CA group (Bonferroni-corrected post hoc test); P2-3, p value for multiple comparisons of EA group and CA group (Bonferroni-corrected post hoc test). PT, p value for the within-group comparison (Friedman test); P0-1, p value for the comparison of baseline (T0) and after 4 weeks (T1) scores (Wilcoxon signed-rank test); P0-2, p value for the comparison of baseline (T0) and after 8 weeks (T2) scores (Wilcoxon signed-rank test).
Patients' impression of the effectiveness of treatment of the entire study population, according to the PGI-I scale, after acupuncture treatments (T1) and at follow-up visit (T2) (n = 60); Pt n (%).
| Patients' impression of the treatment | T1 | T2 |
|---|---|---|
| Very much worse | 0 (0%) | 0 (0%) |
| Much worse | 0 (0%) | 0 (0%) |
| A little worse | 0 (0%) | 0 (0%) |
| No change | 9 (15%) | 11 (18.3%) |
| A little better | 16 (26.7%) | 16 (26.7%) |
| Much better | 17 (28.3%) | 16 (26.7%) |
| Very much better | 18 (30%) | 17 (28.3%) |